Contract Services
Microsize provides Particle Size Reduction, Powder Classification and Analytical Services to a range of pharma stakeholders in need of a center of excellence for their product development and/or commercial manufacturing. Microsize has unmatched expertise in developing milling and micronization processes with a diverse range of API and excipient materials with unique physical property challenges.
High turn feasibility studies can take place within our development suites with as little as 1-5 grams of API. For highly potent compounds including cytotoxics (HPAPIs), a world-class high containment infrastructure, is available in our R&D labs and GMP suites to best match the client stage of development.
Our Customers Include:
- Small biotechs to Big Pharma
- CDMO’s (API, Dosage Form, Integrated)
- Functional Excipient Companies
Types of Molecules:
- Small Molecule APIs and HPAPIs
- Functional Excipients
- NCEs, 505b2s, Generics
Phases of Development Supported:
- Discovery
- Phases I-III
- Commercial Launch
- Generic
Our Services Pipeline
